Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis

ABSTRACT Background Neoadjuvant chemoimmunotherapy (nICT) has emerged as a novel and promising treatment model for esophageal squamous cell carcinoma (ESCC). However, the optimal interval to esophagectomy after nICT remains unclear. This study aimed to explore the impact of a prolonged interval (7–1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui Xu, Zhinuan Hong, Ye Lin, Sunkui Ke, Zhen Chen, Shuhan Xie, Dinghang Chen, Kaiming Peng, Peipei Zhang, Mingduan Chen, Ziyang Han, Jihong Lin, Shuchen Chen, Jinxin Xu, Jinbiao Xie, Mingqiang Kang
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Thoracic Cancer
Subjects:	esophageal squamous cell carcinoma interval to surgery long‐term survival neoadjuvant immunochemotherapy(nICT) pathological response
Online Access:	https://doi.org/10.1111/1759-7714.70019
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
by: Jifeng Feng, et al.
Published: (2024-12-01)

Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety
by: Xiaomin Wang, et al.
Published: (2025-04-01)

Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma
by: Gang Li, et al.
Published: (2025-05-01)

Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
by: Ya-hui Sun, et al.
Published: (2025-07-01)

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma
by: Gaofeng Ding, et al.
Published: (2025-05-01)

Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment 18F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer
by: Mimi Xu, et al.
Published: (2025-02-01)

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
by: Yingyi Li, et al.
Published: (2025-02-01)

The prognostic power of major pathological response in esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multi-center cohort study
by: Shuhan Xie, et al.
Published: (2025-07-01)

Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy
by: Qiang Zhao, et al.
Published: (2025-08-01)

The Lung Cancer Immune Prognostic Score predicts pathologic complete response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy
by: Yuyan Xie, et al.
Published: (2025-04-01)

Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
by: Hai Zhang, et al.
Published: (2025-08-01)

Prognostic factors in locally advanced oesophageal squamous cell carcinoma: a clinical and radiomic analysis of neoadjuvant immunochemotherapy before surgery
by: Yan Zhu, et al.
Published: (2025-03-01)

Circulating Tumor DNA Dynamic Changes in Esophageal Squamous Cell Carcinoma Receiving Immunochemotherapy
by: Yijia Guo, et al.
Published: (2025-05-01)

Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis
by: Chong-Rui Li, et al.
Published: (2025-07-01)

Diffuse and Strong TTF-1 Expression Predicts Response to Pemetrexed-Based Immunochemotherapy in Advanced Lung Adenocarcinoma
by: Yamada J, et al.
Published: (2025-08-01)

Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB–IIIB non-small-cell lung cancer in real-world practice
by: Yongfeng Shuai, et al.
Published: (2025-07-01)

New Information and Communication Technologies as a Factor in Increasing the Youth Political Participation
by: V. V. Mikhaylova
Published: (2018-11-01)

Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy
by: Mengyi Lao, et al.
Published: (2025-08-01)

Development and validation of a nomogram for differentiating immune checkpoint inhibitor-related pneumonitis from pneumonia in patients undergoing immunochemotherapy: a multicenter, real-world, retrospective study
by: Linli Duan, et al.
Published: (2025-05-01)

Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma
by: Qiuying An, et al.
Published: (2025-07-01)

Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches
by: Yanrong Guo, et al.
Published: (2025-05-01)

Efficacy and safety of induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced non-small cell lung cancer: A retrospective study
by: Lipin Liu, et al.
Published: (2025-03-01)

Neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice: an analysis of the clinical outcomes and long-term survival, and the feasibility of using major pathological response as a surrogate endpoint
by: Jiacong Liu, et al.
Published: (2025-04-01)

Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results
by: AK Smol’yaninova, et al.
Published: (2018-10-01)

Expression profile of immunophenotypic marker molecules on B-lymphocytes in patients with chronic lymphocytic leukemia at the stages of immunochemotherapy
by: O. N. Selyutina, et al.
Published: (2022-12-01)

Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Study
by: Li Sun, MD, et al.
Published: (2025-02-01)

Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma
by: Siyou Deng, et al.
Published: (2025-06-01)

Induction immunochemotherapy followed by definitive chemoradiotherapy and consolidation immunotherapy for unresectable stage III non-small cell lung cancer: a multi-institutional retrospective cohort study
by: Zhixue Fu, et al.
Published: (2025-07-01)

Long-term survival in advanced pulmonary large-cell neuroendocrine carcinoma after multi-line immunochemotherapy and anti-angiogenic therapy: a case report
by: Hongming Wang, et al.
Published: (2025-06-01)

An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early‐Stage Follicular Lymphoma
by: Daniel Erku, et al.
Published: (2025-02-01)

Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy
by: A. S. Nozdricheva, et al.
Published: (2024-04-01)

TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC
by: Chaopin Yang, et al.
Published: (2024-12-01)

A case of Hemophagocytic Lymphohistiocytosis presenting as Pyrexia of Unknown Origin
by: Indira M, et al.
Published: (2014-08-01)

Predicting pathological response of resectable esophageal squamous cell carcinoma to neoadjuvant anti-PD-1 with chemotherapy using serum inflammation indexes
by: Peng Song, et al.
Published: (2025-07-01)

Long‐term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single‐center cohort study
by: Yuanzheng Liang, et al.
Published: (2023-02-01)

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01)

Identification of IQGAP3 prognostic potential and involvement in immune cell infiltration in LUAD
by: Mingduan Chen, et al.
Published: (2025-08-01)

Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results)
by: M. A. Mingalimov, et al.
Published: (2024-12-01)

Prognostic value of the log odds of negative lymph nodes/T stage ratio (LONT) in postoperative esophageal cancer: a SEER-based study
by: Yanhong Lin, et al.
Published: (2025-08-01)

First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness
by: KD Kaplanov, et al.
Published: (2018-04-01)